No summary available
4.5
hours
hours
Expires:
11/03/2027
Searching for Solutions
No summary available
3
hours
hours
Expires:
11/03/2027
No summary available
1.5
hours
hours
Expires:
11/03/2027
No summary available
3
hours
hours
Expires:
11/03/2027
Registration is open!
Registration is open for AAPP 2026 in Bellevue, Washington, on Seattle's Eastside! Plan to attend along with 800+ psych pharmacists and take advantage of 23+ hours of CE and 10 hours of BCPP recertification programming. Registration rates increase March 20, 2026.
No summary available
3
hours
hours
Expires:
11/03/2027
Integrating Methadone Into Primary Care: Lessons From Ukraine
Despite strong evidence, there is a large implementation gap in both high-income and LMIC settings.
Antidepressant deprescribing: Slow tapering plus therapy is best way to come off medication, say researchers
The analysis directly compared the effectiveness of different strategies on the rate of relapse either with or without psychological support.
Cognitive Outcomes of Children Exposed to Selective Serotonin Reuptake Inhibitors Through Breast Milk
In this cohort study including children prenatally exposed to SSRIs, additional exposure to SSRIs through breastfeeding was not associated with reduced IQ scores.
Every person’s journey to preparing for and achieving the Board Certified Psychiatric Pharmacist (BCPP) credential is unique. However, hundreds of BCPPs have shared tips and techniques that assisted in their success. Customize the tips below to your background and situation. Good Luck!
Therapeutic Use of Cannabis and Cannabinoids - A Review
Evidence is insufficient for the use of cannabis or cannabinoids for most medical indications. Clear guidance from clinicians is essential to support safe, evidence-based decision-making.
Structural Drivers of the Drop in Opioid Overdose Deaths in the US
This study used our peer-reviewed model of the US opioid crisis to demonstrate how a falling at-risk population combined with probable plateauing of the mortality rate produced the recent decline in US overdose deaths.
Drug Use After Emergency Department-Initiated Injectable Buprenorphine: A Secondary Analysis of the ED-INNOVATION Ancillary Safety and Feasibility Trial
ED-initiated XR-BUP was associated with substantial reductions in opioid and polysubstance use during the first week post-discharge, supporting its role in early overdose risk mitigation and highlighting its value as an ED-based intervention for opioid use disorder.
AMA House of Delegates Passes ASAM’s Resolution to Eliminate Barriers to Medications for OUD
The AMA House passed resolution that directs AMA to advocate at both the state and federal level, for the removal of red flag designations for ordering FDA-approved products to treat OUD. It also calls for the removal of other barriers to medications for OUD, including prior authorizations.
Advocating for the Evidence: Substance Use Disorder Treatment
AAPP supports defining opioid use disorder as a treatable medical condition with a biological basis that is often associated with a history of trauma. Access to MOUD is essential in reducing deaths related to opioid overdose and landmark studies clearly demonstrate that the benefits of MOUD outweigh the risks. Psychiatric pharmacists are encouraged to use this policy brief to support your own advocacy for this gold-standard treatment.
Therapeutic Use of Cannabis and Cannabinoids
Evidence is insufficient for the use of cannabis or cannabinoids for most medical indications.
Thanks to all 2025 donors.
No summary available
No summary available
WHO expert group’s new analysis reaffirms there is no link between vaccines and autism
New analysis from a WHO global expert committee on vaccine safety has found that, based on available evidence, no causal link exists between vaccines and autism spectrum disorders (ASD). The conclusion reaffirms WHO’s position that childhood vaccines do not cause autism.
Cancer and Mental Health: Kelly Gable Shares Lived Experience
Kelly Gable, professor and director of well-being and resilience at Southern Illinois University Edwardsville School of Pharmacy, and member of the AAPP Board, discusses her own cancer journey and how pharmacists need to be more involved and proactive in patients' mental health.